Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
42.82 USD | +17.82% | +9.34% | +90.55% |
04:39pm | Agios Says of Trial of Blood Disorder Drug Mitapivat Met Primary Endpoint; Shares Rise | MT |
02:00pm | Transcript : Agios Pharmaceuticals, Inc. - Special Call |
- Stock Market
- Equities
- AGIO Stock
- News Agios Pharmaceuticals, Inc.
- Press Releases